Effect of Mouse Nerve Growth Factor Combined with Mecobalamin in the Treatment of Peripheral Facial Paralysis
Objective:To investigate the therapeutic effect of mouse nerve growth factor combined with mecobalamin on peripheral facial paralysis and the effect of patients on facial nerve electromyography.Methods:From May 2022 to May 2023,98 patients with peripheral facial paralysis were divided into control group and experimental group,with 49 patients in each group.The control group was treated with mecobalamin tablets,and the experimental group was treated with mouse nerve growth factor for injection combined with mecobalamin tablets.The overall efficacy,disease severity related indicators,and facial nerve electromyography indicators were compared between the two groups.Results:After treatment,the total effective rate of the experimental group was 91.84%,which was higher than 75.51%of the control group(P<0.05).The scores of Sunnybrook Facial Grading System(SFGS)and Portmann's Simple Scale(RPA)in the experimental group were higher than those in the control group(P<0.05).The conduction latency of the experimental group was shorter than that of the control group,and the amplitude ratio of the affected side to the healthy side was higher than that of the control group(P<0.05).Conclusion:For patients with peripheral facial paralysis,mouse nerve growth factor combined with mecobalamin can improve the therapeutic effect,promote the recovery of the patient's condition,and improve the patient's facial nerve electromyography index.
NETL
NSTL
万方数据
